Navigation Links
CHPA Responds to Kentucky Senate Judiciary Passage of Senate Bill 3
Date:3/1/2012

WASHINGTON, March 1, 2012 /PRNewswire/ -- The Consumer Healthcare Products Association (CHPA) released the following statement after the Kentucky Senate Judiciary Committee passed Senate Bill 3, legislation that would impose significant restrictions on safe and effective medicines containing pseudoephedrine (PSE), such as Advil Cold & Sinus, Allegra-D, Claritin-D, Mucinex D, and Sudafed.  SB 3 would limit the amount of PSE consumers can buy to 15 grams a year and 3.6 grams a month. The measure now moves to the full Senate for consideration.  

"Severe restrictions on cold and allergy medicines containing pseudoephedrine will prevent chronic allergy suffers and many Kentucky families from accessing affordable, quality healthcare they rely upon," said Scott Melville, president and chief executive officer of the CHPA. "For thousands of Kentuckians—especially those who suffer from seasonal allergy symptoms—there's absolutely no difference between a prescription mandate and Senate Bill 3, especially given the fact that the Commonwealth of Kentucky has one of the longest allergy seasons in the country. The significant gram limit called for in SB 3 would lead to involuntary time off work, lost wages and increased health expenses for many responsible Kentucky families and workers."

"Kentucky Senators made the right decision when they shut the door on SB 50 last week. We are hopeful that the Kentucky Senate will listen to their constituents and enact anti-meth policies that target criminals without burdening responsible workers and families with additional barriers to these legal medicines."

www.chpa-info.org

CHPA is the 131-year-old-trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. CHPA Responds to Prescription Mandate Cost Implications Outlined in Oklahoma Economic Impact Study
2. Questcor Pharmaceuticals Responds to Questions From Investor Blog
3. AVMA Responds to Federal Order Limiting Use of Antibiotics In Food Animals
4. Ampio Responds to Recent Publications by Anonymous Short Sellers
5. Nationwide Coalition Responds to Express Scripts CEO Statement: "I Cant Stop Certain Pharmacies From Going Out of Business"
6. China Medical Technologies Responds to the Allegations Raised by Glaucus Research Group
7. International Academy of Compounding Pharmacists (IACP) Responds to FDAs Appeal of the U.S. District Court Ruling on Pharmacy Compounding
8. Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimers Patent Application
9. NeuroSigma Responds to Substantial Interest Generated by NPR Story on Promising Epilepsy Clinical Trial
10. Cellestis Responds to World Health Organization Guidance on Use of Blood Tests for Active Tuberculosis
11. Takeda Responds to U.S. Food and Drug Administration Update to Safety Review of ACTOS (pioglitazone HCl)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):